Keyphrases
Matrix metalloproteinase-2 (MMP-2)
100%
Activation System
100%
Focal Cerebral Ischemia
100%
Plasminogen Activator inhibitor-1 (PAI-1)
33%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
33%
Transient Middle Cerebral Artery Occlusion (tMCAO)
33%
U-PA
33%
Tissue Plasminogen Activator (t-PA)
22%
Ischemic Core
22%
Cellular Compartments
11%
Expression Pattern
11%
Ischemic Region
11%
RNA Transcripts
11%
Urokinase-type Plasminogen Activator
11%
Protease
11%
Baboon
11%
Reperfusion
11%
Primates
11%
Basal Ganglia
11%
In Situ Hybridization
11%
Striatum
11%
Microvessels
11%
Adolescent Males
11%
MT1-MMP
11%
Basal Lamina
11%
Latent Form
11%
MT3-MMP
11%
Indirect Activation
11%
Neuroscience
MMP2
100%
Brain Ischemia
100%
Middle Cerebral Artery
33%
Plasminogen Activator Inhibitor-1
33%
Tissue Plasminogen Activator
22%
Proteinase Activated Receptor 1
22%
Striatum
11%
Basal Ganglia
11%
Basal Lamina
11%
Proteinase
11%
Urokinase
11%
Matrix Metalloproteinase 14
11%
Matrix Metalloproteinase 16
11%
Microvessel
11%
In Situ Hybridization
11%
Receptor
11%
Messenger RNA
11%